<DOC>
	<DOC>NCT00971152</DOC>
	<brief_summary>This goal of this study is to evaluate the outcomes from in vitro fertilization cycles where a 450 IU daily dose of gonadotropins is administered compared to those where a 600 IU daily dose is administered for women who are at risk of a poor ovarian response in order to determine if one dose or the other results in improved cycle outcomes.</brief_summary>
	<brief_title>Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<criteria>RESIDENT OF CANADA Premenopausal Age 40 years or less at the time of enrollment At risk of a poor ovarian response defined as: either &lt;5 oocytes or &lt;8 follicles in a previous cycle, FSH &gt; 10 IU/L, AMH &lt; 1 pg/ml , antral follicle count less or equal to 8 or previous IVF cancellation Primary infertility or secondary Not previously undertaken a cycle that was included in this study Simultaneous participation in another clinical trial Body mass index (BMI) &gt; 38 kg/m2 Early follicular phase (day 24) serum FSH level &gt; 20 mIU/ml Any contraindication to being pregnant and carrying a pregnancy to term Contraindication for the use of Estrace速 , Suprefact速, Menopur速, Bravelle速, hCG, and luteal phase support medication Any ovarian or abdominal abnormality that may interfere with adequate transvaginal ultrasound evaluation Administration of any investigational drugs within three months prior to study enrollment Patient not able to communicate adequately with the investigators and to comply with the requirements of the entire study Positive results of screening of either partner for HIV antibodies, Hepatitis B (other than for surface antibodies present after vaccination) or Hepatitis C Unwillingness to give written informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>IVF</keyword>
	<keyword>dose comparison of gonadotrophins</keyword>
	<keyword>poor responder to ovarian stimulation</keyword>
</DOC>